Cite
APA Citation
Pethusamy, K., Seethy, A., Dhar, R., Karmakar, A., Chaudhary, S., Bakhshi, S., P, J. K., Chopra, A., Chauhan, S. S., & Karmakar, S. (2022). loss of TET2 with reduced genomic 5-hmC is associated with adverse-risk AML. Leukemia & lymphoma, 63(14), 3426–3432. http://access.bl.uk/ark:/81055/vdc_100174903625.0x00003f